Quality & Risk
FDA Form 483
In one line
Notice of inspectional observations issued at the conclusion of an FDA inspection.
Definition
Form FDA 483 lists conditions or practices observed by an investigator that, in their judgment, may constitute violations of the Food, Drug, and Cosmetic Act and related regulations.
A 483 is issued at the end of an inspection and discussed at the close-out meeting. It is not a final agency determination, but a written response within 15 business days is strongly advised, as FDA considers timely, thorough responses when deciding whether to escalate to a warning letter. Responses should address each observation with root cause, corrections, systemic actions and evidence. 483s are public and can be obtained through FOIA.
Why it matters
A Form 483 is not itself a final agency action. Manufacturer responses and corrections influence whether a Warning Letter follows.
Common pitfalls
- •Not responding to a Form 483 in a timely and comprehensive manner can escalate the issue to a Warning Letter or other enforcement actions.
- •Dismissing observations on a Form 483 as minor without a thorough investigation and root cause analysis is a critical mistake.
- •Failing to implement proposed corrective actions effectively, leading to repeat observations in subsequent inspections, undermines trust with the FDA.
- •Misinterpreting the Form 483 as a final judgment rather than an opportunity to demonstrate commitment to quality and compliance is a common pitfall.
- •Providing generic or vague responses without specific evidence of implementation or timelines for completion is ineffective.
Sources
- FDA Form 483 · FDA
- AAMI - Quality Systems Resources · AAMI
- MDIC Case for Quality · MDIC